United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Curi Bio acquires Dana Solutions to boost drug discovery platforms Curi Bio, a developer of human iPSC-based platforms for drug discovery, has acquired Dana Solutions, a provider of… bypharmanewsdailyJuly 25, 2020